Cboe BZX · FIXXHealthcarePharmaceuticals

Leverage Shares 2X Long FIX Daily ETF (FIXX)

$13.04+0.13%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$13.04▼ 4.97% in range
Sep 11, 2026Low $11.87 · High $13.72Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

Leverage Shares 2X Long FIX Daily ETF closed at $13.04 on Sep 28, up 0.13%, 5.0% below its highest close since Mar 28. Volume of 2.3K shares was 0.47× its 20-day average (below normal).

Short interest was 4.9K shares at the Sep 15 settlement, up 924.6% from the prior report (1.2 days to cover).

Market cap—
Revenue · quarter$0.00—
Diluted EPS$-0.44—
P/E · TTM—
Net margin—
Dividend yieldNone
Range since Mar 2811.87 – 13.72−5.0% from high
Volume2.3K0.47× 20-day avg
Volatility · 60d—Annualised
Short % of float—1.2 days to cover
Net cash$106.3MCash $106.3M
Next earnings—Not scheduled
Split-adjusted performance
1W +2.8%1M —3M —6M —YTD —1Y —3Y −38.1%5Y −91.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 423 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −2.9%, revenue growth +6.4%, net margin −41.2%, P/E 16.2×.

Short interest

Details →
Shares short4.9K+924.6% vs prior
Days to cover1.2Settled Sep 15
% of float—
Short vol. 10d57.0%of daily volume

News about Leverage Shares 2X Long FIX Daily ETF

All news →

No recent articles focused on Leverage Shares 2X Long FIX Daily ETF.

Quick answers

What sector is FIXX in?
Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology